Evolution Advisers’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$32K Buy
78
+3
+4% +$1.11K 0.01% 122
2026
Q1
$20K Hold
75
0.01% 118
2025
Q4
$24K Hold
75
0.01% 117
2025
Q3
$26K Hold
75
0.01% 113
2025
Q2
$23K Hold
75
0.01% 113
2025
Q1
$39K Sell
75
-2
-3% -$1.02K 0.02% 99
2024
Q4
$38K Hold
77
0.02% 101
2024
Q3
$45K Hold
77
0.02% 93
2024
Q2
$39K Buy
77
+2
+3% +$980 0.02% 95
2024
Q1
$38K Sell
75
-1
-1% -$508 0.02% 98
2023
Q4
$41K Buy
76
+1
+1% +$533 0.03% 97
2023
Q3
$38K Sell
75
-1,119
-94% -$551K 0.03% 73
2023
Q2
$574K Buy
1,194
+951
+391% +$465K 0.41% 20
2023
Q1
$115K Buy
243
+168
+224% +$81.1K 0.08% 41
2022
Q4
$39K Hold
75
0.03% 73
2022
Q3
$37K Hold
75
0.03% 66
2022
Q2
$38K Hold
75
0.03% 68
2022
Q1
$38K Buy
+75
New +$36.2K 0.03% 72

Other funds holding UNH

Evolution Advisers's UNH Position: Q2 2026 in Review

Evolution Advisers increased its UnitedHealth (UNH) stake by 4% in Q2 2026, buying an estimated $1.11K and bringing the position to 78 shares worth $32K. The position accounts for 0.01% of the portfolio, ranked #122.

Evolution Advisers first reported a position in UNH in Q1 2022 and has held it in 18 quarters since. The position peaked at $574K in Q2 2023. 1,651 funds tracked by Wall St. Rank hold UNH as of Q2 2026.

  • Evolution Advisers held 78 shares of UnitedHealth worth $32K as of Q2 2026.
  • Evolution Advisers bought 3 UnitedHealth shares in Q2 2026, an estimated $1.11K.
  • UnitedHealth made up 0.01% of Evolution Advisers's portfolio in Q2 2026, its #122 holding.
  • Evolution Advisers first reported a position in UnitedHealth in Q1 2022 and has held it in 18 quarters since.
  • Evolution Advisers's UnitedHealth position peaked at $574K in Q2 2023.
  • 1,651 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2026.

Based on Evolution Advisers's 13F filing for Q2 2026, filed 31 Jul 2026.